EXCEDRIN MIGRAINE 2'S- 25 CT recall — Class II (D-0270-2026) · pharmaranks
Class IIOngoing
EXCEDRIN MIGRAINE 2'S- 25 CT recall
FDA recall D-0270-2026 · initiated Dec 26, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
Details
Product
EXCEDRIN MIGRAINE 2'S- 25 CT
Recalling company
GOLD STAR DISTRIBUTION INC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Dec 26, 2025
FDA report date
Jan 21, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.